ARTICLE | Clinical News
Atrovent HFA regulatory update
November 22, 2004 8:00 AM UTC
FDA approved Atrovent HFA inhalation aerosol, a reformulation of Atrovent (CFC), for bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphyse...